vs
美国运通（AXP）与RECURSION PHARMACEUTICALS, INC.（RXRX）财务数据对比。点击上方公司名可切换其他公司
RECURSION PHARMACEUTICALS, INC.的季度营收约是美国运通的1.9倍（$35.5M vs $18.9M），美国运通净利率更高（15.7% vs -304.2%，领先320.0%），RECURSION PHARMACEUTICALS, INC.同比增速更快（681.7% vs 11.4%），过去两年RECURSION PHARMACEUTICALS, INC.的营收复合增速更高（60.5% vs -95.6%）
美国运通是全球知名的支付服务提供商，主营签账卡、信用卡产品及旅行相关服务，下设全球消费者服务、全球商业服务、全球商户与网络服务三大业务板块，还提供支付融资、网络服务、应付账款费用管理、旅行生活服务等多元解决方案。
Recursion Pharmaceuticals是一家临床阶段生物技术企业，依托人工智能技术和高通量生物实验体系，开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法，核心市场覆盖北美，与全球多家生物制药企业合作推进在研管线落地。
AXP vs RXRX — 直观对比
营收规模更大
RXRX
是对方的1.9倍
$18.9M
营收增速更快
RXRX
高出670.3%
11.4%
净利率更高
AXP
高出320.0%
-304.2%
两年增速更快
RXRX
近两年复合增速
-95.6%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $18.9M | $35.5M |
| 净利润 | $3.0M | $-108.1M |
| 毛利率 | — | 59.8% |
| 营业利润率 | — | -304.8% |
| 净利率 | 15.7% | -304.2% |
| 营收同比 | 11.4% | 681.7% |
| 净利润同比 | 15.0% | 39.6% |
| 每股收益（稀释后） | — | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AXPRXRX
| Q1 26 | $18.9M | — | ||
| Q4 25 | $10.9B | $35.5M | ||
| Q3 25 | $10.4B | $5.2M | ||
| Q2 25 | $10.3B | $19.2M | ||
| Q1 25 | $9.6B | $14.7M | ||
| Q4 24 | $10.0B | $4.5M | ||
| Q3 24 | $9.7B | $26.1M | ||
| Q2 24 | $9.8B | $14.4M |
净利润AXPRXRX
| Q1 26 | $3.0M | — | ||
| Q4 25 | $2.5B | $-108.1M | ||
| Q3 25 | $2.9B | $-162.3M | ||
| Q2 25 | $2.9B | $-171.9M | ||
| Q1 25 | $2.6B | $-202.5M | ||
| Q4 24 | $2.2B | $-178.9M | ||
| Q3 24 | $2.5B | $-95.8M | ||
| Q2 24 | $3.0B | $-97.5M |
毛利率AXPRXRX
| Q1 26 | — | — | ||
| Q4 25 | — | 59.8% | ||
| Q3 25 | — | -183.8% | ||
| Q2 25 | — | -4.9% | ||
| Q1 25 | — | -48.0% | ||
| Q4 24 | — | -181.4% | ||
| Q3 24 | — | 53.7% | ||
| Q2 24 | — | 36.2% |
营业利润率AXPRXRX
| Q1 26 | — | — | ||
| Q4 25 | 28.2% | -304.8% | ||
| Q3 25 | 36.7% | -3327.6% | ||
| Q2 25 | 34.4% | -916.8% | ||
| Q1 25 | 34.6% | -1297.9% | ||
| Q4 24 | 27.7% | -4042.4% | ||
| Q3 24 | 33.0% | -377.1% | ||
| Q2 24 | 38.6% | -697.4% |
净利率AXPRXRX
| Q1 26 | 15.7% | — | ||
| Q4 25 | 22.5% | -304.2% | ||
| Q3 25 | 27.9% | -3135.3% | ||
| Q2 25 | 28.0% | -894.2% | ||
| Q1 25 | 26.8% | -1373.3% | ||
| Q4 24 | 21.8% | -3935.5% | ||
| Q3 24 | 25.8% | -367.5% | ||
| Q2 24 | 30.7% | -676.6% |
每股收益（稀释后）AXPRXRX
| Q1 26 | — | — | ||
| Q4 25 | $3.52 | $-0.17 | ||
| Q3 25 | $4.14 | $-0.36 | ||
| Q2 25 | $4.08 | $-0.41 | ||
| Q1 25 | $3.64 | $-0.50 | ||
| Q4 24 | $3.04 | $-0.56 | ||
| Q3 24 | $3.49 | $-0.34 | ||
| Q2 24 | $4.15 | $-0.40 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $743.3M |
| 总债务越低越好 | $60.4M | $9.6M |
| 股东权益账面价值 | $34.0M | $1.1B |
| 总资产 | $308.9M | $1.5B |
| 负债/权益比越低杠杆越低 | 1.78× | 0.01× |
8季度趋势，按日历期对齐
现金及短期投资AXPRXRX
| Q1 26 | — | — | ||
| Q4 25 | $742.0M | $743.3M | ||
| Q3 25 | $1.3B | $659.8M | ||
| Q2 25 | $197.0M | $525.1M | ||
| Q1 25 | $261.0M | $500.5M | ||
| Q4 24 | $221.0M | $594.4M | ||
| Q3 24 | $120.0M | $427.6M | ||
| Q2 24 | $188.0M | $474.3M |
总债务AXPRXRX
| Q1 26 | $60.4M | — | ||
| Q4 25 | $56.4B | $9.6M | ||
| Q3 25 | $57.8B | $11.9M | ||
| Q2 25 | $58.2B | $14.2M | ||
| Q1 25 | $51.2B | $16.4M | ||
| Q4 24 | $49.7B | $19.0M | ||
| Q3 24 | $53.5B | $20.5M | ||
| Q2 24 | $51.5B | $22.9M |
股东权益AXPRXRX
| Q1 26 | $34.0M | — | ||
| Q4 25 | $33.5B | $1.1B | ||
| Q3 25 | $32.4B | $1.0B | ||
| Q2 25 | $32.3B | $919.1M | ||
| Q1 25 | $31.2B | $933.9M | ||
| Q4 24 | $30.3B | $1.0B | ||
| Q3 24 | $29.7B | $524.6M | ||
| Q2 24 | $29.5B | $584.4M |
总资产AXPRXRX
| Q1 26 | $308.9M | — | ||
| Q4 25 | $300.1B | $1.5B | ||
| Q3 25 | $297.6B | $1.4B | ||
| Q2 25 | $295.6B | $1.3B | ||
| Q1 25 | $282.2B | $1.3B | ||
| Q4 24 | $271.5B | $1.4B | ||
| Q3 24 | $271.0B | $726.5M | ||
| Q2 24 | $272.2B | $775.9M |
负债/权益比AXPRXRX
| Q1 26 | 1.78× | — | ||
| Q4 25 | 1.68× | 0.01× | ||
| Q3 25 | 1.78× | 0.01× | ||
| Q2 25 | 1.80× | 0.02× | ||
| Q1 25 | 1.64× | 0.02× | ||
| Q4 24 | 1.64× | 0.02× | ||
| Q3 24 | 1.80× | 0.04× | ||
| Q2 24 | 1.74× | 0.04× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | — | $-47.3M |
| 自由现金流率自由现金流/营收 | — | -133.1% |
| 资本支出强度资本支出/营收 | — | 3.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-378.3M |
8季度趋势，按日历期对齐
经营现金流AXPRXRX
| Q1 26 | — | — | ||
| Q4 25 | $3.1B | $-46.1M | ||
| Q3 25 | $6.2B | $-117.4M | ||
| Q2 25 | $4.4B | $-76.4M | ||
| Q1 25 | $4.8B | $-132.0M | ||
| Q4 24 | $5.8B | $-115.4M | ||
| Q3 24 | $-1.8B | $-59.2M | ||
| Q2 24 | $4.5B | $-82.2M |
自由现金流AXPRXRX
| Q1 26 | — | — | ||
| Q4 25 | $2.3B | $-47.3M | ||
| Q3 25 | $5.6B | $-117.6M | ||
| Q2 25 | $3.7B | $-79.6M | ||
| Q1 25 | $4.3B | $-133.8M | ||
| Q4 24 | $5.3B | $-116.7M | ||
| Q3 24 | $-2.3B | $-63.8M | ||
| Q2 24 | $4.0B | $-83.4M |
自由现金流率AXPRXRX
| Q1 26 | — | — | ||
| Q4 25 | 21.4% | -133.1% | ||
| Q3 25 | 53.6% | -2272.5% | ||
| Q2 25 | 36.3% | -413.9% | ||
| Q1 25 | 45.0% | -907.4% | ||
| Q4 24 | 53.1% | -2567.7% | ||
| Q3 24 | -23.3% | -244.6% | ||
| Q2 24 | 40.4% | -578.5% |
资本支出强度AXPRXRX
| Q1 26 | — | — | ||
| Q4 25 | 6.6% | 3.5% | ||
| Q3 25 | 6.3% | 4.7% | ||
| Q2 25 | 6.0% | 16.4% | ||
| Q1 25 | 4.5% | 12.4% | ||
| Q4 24 | 5.0% | 28.6% | ||
| Q3 24 | 4.7% | 17.5% | ||
| Q2 24 | 5.8% | 8.2% |
现金转化率AXPRXRX
| Q1 26 | — | — | ||
| Q4 25 | 1.25× | — | ||
| Q3 25 | 2.15× | — | ||
| Q2 25 | 1.51× | — | ||
| Q1 25 | 1.84× | — | ||
| Q4 24 | 2.66× | — | ||
| Q3 24 | -0.72× | — | ||
| Q2 24 | 1.50× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AXP
| Discount revenue | $9.5M | 50% |
| Other | $8.9M | 47% |
| Deposits with banks and other | $512.0K | 3% |
RXRX
暂无分部数据
